{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:05:29Z","timestamp":1789495529362,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.talanta.2020.121945","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T10:47:17Z","timestamp":1607165237000},"page":"121945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Therapeutic drug monitoring of tranexamic acid in plasma and urine of renally impaired patients using solid phase microextraction"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4141-9070","authenticated-orcid":false,"given":"Nikita","family":"Looby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Vasiljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8859-3194","authenticated-orcid":false,"given":"Nathaly","family":"Reyes-Garc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4486-7151","authenticated-orcid":false,"given":"Anna","family":"Roszkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bojko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6160-6506","authenticated-orcid":false,"given":"Marcin","family":"W\u0105sowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Jerath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9975-5811","authenticated-orcid":false,"given":"Janusz","family":"Pawliszyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2020.121945_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.talanta.2020.121945_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/ALN.0000000000000688","article-title":"Antifibrinolytic therapy for cardiac surgery: an update","volume":"123","author":"Koster","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.talanta.2020.121945_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jchromb.2011.01.005","article-title":"Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients","volume":"879","author":"Abou-Diwan","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121945_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11708","article-title":"Metabolic phenotyping in clinical and surgical environments","volume":"491","author":"Nicholson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.talanta.2020.121945_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/bdd.1941","article-title":"Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment","volume":"36","author":"Yang","year":"2015","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.talanta.2020.121945_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cca.2010.01.005","article-title":"A validated assay for the quantitative analysis of tranexamic acid in human serum by liquid chromatography coupled with electrospray ionization mass spectrometry","volume":"411","author":"Grassin Delyle","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121945_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpba.2017.04.024","article-title":"LC\u2013MS\/MS determination of tranexamic acid in human plasma after phospholipid clean-up","volume":"141","author":"Fabresse","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121945_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chroma.2014.12.020","article-title":"Determination of tranexamic acid in various matrices using microwave-assisted derivatization followed by dispersive liquid-liquid microextraction","volume":"1377","author":"Liao","year":"2015","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.talanta.2020.121945_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1365\/s10337-007-0323-6","article-title":"Optimization and validation of an HPLC-UV method for determination of tranexamic acid in a dosage form and in human urine","volume":"66","author":"Hadad","year":"2007","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2020.121945_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00554669","article-title":"Pharmacokinetics and bioavailability of tranexamic acid","volume":"20","author":"Pilbrant","year":"1981","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.talanta.2020.121945_bib11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/bja\/aet255","article-title":"Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass","volume":"111","author":"Grassin-Delyle","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.talanta.2020.121945_bib12","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1365-2044.2012.07266.x","article-title":"Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass","volume":"67","author":"Sharma","year":"2012","journal-title":"Anaesthesia"},{"key":"10.1016\/j.talanta.2020.121945_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1373\/clinchem.2014.237164","article-title":"Ambient ionization mass spectrometry for point-of- care diagnostics and other clinical measurements","volume":"62","author":"Ferreira","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.talanta.2020.121945_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijms.2017.04.008","article-title":"State-of-the-art mass spectrometry for point-of-care and other applications: a hands-on intensive short course for undergraduate students","volume":"417","author":"Fedick","year":"2017","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121945_bib15","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.jchromb.2011.08.003","article-title":"Determination of tranexamic acid concentration by solid phase microextraction and liquid chromatography-tandem mass spectrometry: first step to in vivo analysis","volume":"879","author":"Bojko","year":"2011","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121945_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/FTD.0b013e3182400540","article-title":"Therapeutic monitoring of tranexamic acid concentration: high-throughput analysis with solid-phase microextraction","volume":"34","author":"Bojko","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.talanta.2020.121945_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2014.01.026","article-title":"Development of SPME method for concomitant sample preparation of rocuronium bromide and tranexamic acid in plasma","volume":"92","author":"Gorynski","year":"2014","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121945_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12630-011-9614-3","article-title":"Use of a novel technique, solid phase microextraction, to measure tranexamic acid in patients undergoing cardiac surgery","volume":"59","author":"W\u0105sowicz","year":"2012","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.talanta.2020.121945_bib19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1213\/ANE.0000000000002724","article-title":"Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction","volume":"127","author":"Jerath","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.talanta.2020.121945_bib20","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.talanta.2020.121945_bib21","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1039\/C9AN00041K","article-title":"Solid phase microextraction coupled to mass spectrometry: via a microfluidic open interface for rapid therapeutic drug monitoring","volume":"144","author":"Looby","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.talanta.2020.121945_bib22","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1021\/ac2010185","article-title":"Optimization of the coating procedure for a high-throughput 96-blade solid phase microextraction system coupled with LC-MS\/MS for analysis of complex samples","volume":"83","author":"Mirnaghi","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121945_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chroma.2014.11.047","article-title":"High throughput quantification of prohibited substances in plasma using thin film solid phase microextraction","volume":"1374","author":"Reyes-Garc\u00e9s","year":"2014","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.talanta.2020.121945_bib24","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.1021\/acs.analchem.5b01849","article-title":"Solid phase microextraction devices prepared on plastic support as potential single-use samplers for bioanalytical applications","volume":"87","author":"Reyes-Garc\u00e9s","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121945_bib25","article-title":"Supel-select HLB SPE for pharmaceutical analysis | sigma-aldrich","volume":"27","author":"Santasania","year":"2016","journal-title":"Report. US. (n.d.)"},{"key":"10.1016\/j.talanta.2020.121945_bib26","unstructured":"Chemicalize - Instant Cheminformatics Solutions, (n.d.). https:\/\/chemicalize.com\/#\/calculation (accessed September 10, 2019)."},{"key":"10.1016\/j.talanta.2020.121945_bib27","series-title":"Biochemical Pharmacology","author":"Palmer","year":"1961"},{"key":"10.1016\/j.talanta.2020.121945_bib28","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020312364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020312364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:23:48Z","timestamp":1770924228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914020312364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"alternative-id":["S0039914020312364"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121945","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic drug monitoring of tranexamic acid in plasma and urine of renally impaired patients using solid phase microextraction","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121945"}}